Bank of Montreal’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-28,534
| Closed | -$2.66M | – | 4383 |
|
|
2021
Q4 | $2.66M | Buy |
28,534
+18,798
| +193% | +$1.24M | ﹤0.01% | 1465 |
|
|
2021
Q3 | $592K | Buy |
9,736
+5,773
| +146% | +$341K | ﹤0.01% | 2782 |
|
|
2021
Q2 | $281K | Sell |
3,963
-4,865
| -55% | -$317K | ﹤0.01% | 3086 |
|
|
2021
Q1 | $587K | Sell |
8,828
-4,332
| -33% | -$333K | ﹤0.01% | 2544 |
|
|
2020
Q4 | $978K | Buy |
13,160
+7,900
| +150% | +$592K | ﹤0.01% | 2259 |
|
|
2020
Q3 | $406K | Sell |
5,260
-1,426
| -21% | -$95.1K | ﹤0.01% | 2422 |
|
|
2020
Q2 | $440K | Buy |
6,686
+4,808
| +256% | +$265K | ﹤0.01% | 2329 |
|
|
2020
Q1 | $83K | Sell |
1,878
-13,451
| -88% | -$617K | ﹤0.01% | 2677 |
|
|
2019
Q4 | $696K | Sell |
15,329
-18,661
| -55% | -$882K | ﹤0.01% | 2480 |
|
|
2019
Q3 | $1.56M | Buy |
33,990
+29,806
| +712% | +$1.68M | ﹤0.01% | 1848 |
|
|
2019
Q2 | $245K | Buy |
+4,184
| New | +$216K | ﹤0.01% | 2816 |
|
|
2019
Q1 | – | Sell |
-703
| Closed | -$27K | – | 4931 |
|
|
2018
Q4 | $27K | Buy |
703
+360
| +105% | +$14.1K | ﹤0.01% | 3541 |
|
|
2018
Q3 | $16K | Sell |
343
-10
| -3% | -$405 | ﹤0.01% | 3786 |
|
|
2018
Q2 | $15K | Buy |
+353
| New | +$15.2K | ﹤0.01% | 3851 |
|
|
2018
Q1 | – | Sell |
-200
| Closed | -$7K | – | 4418 |
|
|
2017
Q4 | $7K | Sell |
200
-11,800
| -98% | -$336K | ﹤0.01% | 3883 |
|
|
2017
Q3 | $306K | Buy |
12,000
+11,935
| +18,362% | +$274K | ﹤0.01% | 2484 |
|
|
2017
Q2 | $1K | Buy |
+65
| New | +$891 | ﹤0.01% | 4106 |
|
|
2016
Q2 | – | Sell |
-139
| Closed | -$3K | – | 4405 |
|
|
2016
Q1 | $3K | Sell |
139
-185
| -57% | -$2.96K | ﹤0.01% | 3936 |
|
|
2015
Q4 | $7K | Buy |
324
+185
| +133% | +$3.77K | ﹤0.01% | 3723 |
|
|
2015
Q3 | $3K | Hold |
139
| – | – | ﹤0.01% | 3753 |
|
|
2015
Q2 | $6K | Hold |
139
| – | – | ﹤0.01% | 3609 |
|
|
2015
Q1 | $6K | Hold |
139
| – | – | ﹤0.01% | 3610 |
|
|
2014
Q4 | $5K | Buy |
+139
| New | +$5.64K | ﹤0.01% | 3712 |
|
|
2014
Q3 | – | Sell |
-604
| Closed | -$35K | – | 4536 |
|
|
2014
Q2 | $35K | Buy |
604
+239
| +65% | +$15K | ﹤0.01% | 3360 |
|
|
2014
Q1 | $23K | Buy |
+365
| New | +$24.2K | ﹤0.01% | 3441 |
|
Bank of Montreal's ARNA Position: Q1 2022 in Review
Bank of Montreal sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 28,534 shares — an estimated $2.66M sold.
Bank of Montreal first reported a position in ARNA in Q1 2014 and held it in 25 quarters. The position peaked at $2.66M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Bank of Montreal reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Bank of Montreal sold 28,534 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.66M.
- Bank of Montreal first reported a position in Arena Pharmaceuticals Inc in Q1 2014 and held it in 25 quarters.
- Bank of Montreal's Arena Pharmaceuticals Inc position peaked at $2.66M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Bank of Montreal's 13F filing for Q1 2022, filed 12 May 2022.